PE121998A1 - Formulacion parenteral de dibenz(b,f)azepin-5-carboxamida - Google Patents

Formulacion parenteral de dibenz(b,f)azepin-5-carboxamida

Info

Publication number
PE121998A1
PE121998A1 PE1998000950A PE00095098A PE121998A1 PE 121998 A1 PE121998 A1 PE 121998A1 PE 1998000950 A PE1998000950 A PE 1998000950A PE 00095098 A PE00095098 A PE 00095098A PE 121998 A1 PE121998 A1 PE 121998A1
Authority
PE
Peru
Prior art keywords
dibenz
azepin
carboxamide
composition
water
Prior art date
Application number
PE1998000950A
Other languages
English (en)
Inventor
Hoogevest Peter Van
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE121998A1 publication Critical patent/PE121998A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

SE REFIERE A UNA COMPOSICION PARENTERAL QUE COMPRENDE 5H-DIBENZ(b,f)AZEPIN-5-CARBOXAMIDA, SIENDO COMPUESTOS PREFERIDOS CARBAMAZEPINA, 10-OXACARBAZEPINA Y 10-HIDROXI-10,11-TETRAHIDROCARBAMAZEPINA; b)AGUA O UN SOLVENTE BASADO EN AGUA, OPCIONALMENTE CON UN COSOLVENTE ORGANICO; LA FORMULACION NO CONTIENE OTROS AUXILIARES DE SOLUBILIZACION. LA COMPOSICION COMPRENDE ADEMAS GLUCOSA. TAMBIEN SE REFIERE A OTRA COMPOSICION QUE COMPRENDE 10-HIDROXI-10,11-TETRAHIDROCARBAMAZEPINA Y AGUA, ADEMAS COMPRENDE UN AGENTE ISOTONICO COMO GLUCOSA. LA COMPOSICION PUEDE SER UTIL PARA EL TRATAMIENTO DE LA EPILEPSIA
PE1998000950A 1997-10-09 1998-10-07 Formulacion parenteral de dibenz(b,f)azepin-5-carboxamida PE121998A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721497.7A GB9721497D0 (en) 1997-10-09 1997-10-09 Organic compounds

Publications (1)

Publication Number Publication Date
PE121998A1 true PE121998A1 (es) 1999-12-08

Family

ID=10820342

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1998000950A PE121998A1 (es) 1997-10-09 1998-10-07 Formulacion parenteral de dibenz(b,f)azepin-5-carboxamida

Country Status (32)

Country Link
US (2) US6316417B1 (es)
EP (1) EP1033988B1 (es)
JP (2) JP2001519395A (es)
KR (1) KR100760326B1 (es)
CN (1) CN1210032C (es)
AR (1) AR015465A1 (es)
AT (1) ATE257383T1 (es)
AU (1) AU748034B2 (es)
BR (1) BR9812861A (es)
CA (1) CA2304661C (es)
CO (2) CO4950520A1 (es)
CZ (1) CZ298900B6 (es)
DE (1) DE69821024T2 (es)
DK (1) DK1033988T3 (es)
ES (1) ES2214738T3 (es)
GB (1) GB9721497D0 (es)
HK (1) HK1031824A1 (es)
HU (1) HU226106B1 (es)
ID (1) ID24134A (es)
IL (1) IL135123A0 (es)
MY (1) MY122129A (es)
NO (1) NO327263B1 (es)
NZ (1) NZ503526A (es)
PE (1) PE121998A1 (es)
PL (1) PL192287B1 (es)
PT (1) PT1033988E (es)
RU (1) RU2242231C2 (es)
SK (1) SK286253B6 (es)
TR (1) TR200000870T2 (es)
TW (1) TW584563B (es)
WO (1) WO1999018966A1 (es)
ZA (1) ZA989183B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US20100204178A1 (en) 2006-10-02 2010-08-12 James Cloyd Novel parenteral carbamazepine formulation
JP5284096B2 (ja) 2005-09-30 2013-09-11 ルンドベック エルエルシー 新規非経口カルバマゼピン製剤
CA2635797C (en) * 2006-02-09 2015-03-31 Macusight, Inc. Stable formulations, and methods of their preparation and use
US8372431B2 (en) 2007-10-26 2013-02-12 Bial-Portela & C.A., S.A. Pharmaceutical composition comprising licarbazepine acetate
CN101711739B (zh) * 2008-10-08 2012-07-04 中国人民解放军军事医学科学院毒物药物研究所 卡马西平的口服药物组合物
CN105726466A (zh) * 2014-12-10 2016-07-06 辽宁药联制药有限公司 一种奥卡西平注射剂及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE133079T1 (de) * 1989-12-27 1996-02-15 Ciba Geigy Ag Vorrichtung zum homogenisieren der inhomogenen lichtverteilung eines laserstrahllichtbündels
EP0435826A1 (de) 1989-12-27 1991-07-03 Ciba-Geigy Ag Intravenöse Lösungen für Status Epilepticus
US5284662A (en) * 1990-10-01 1994-02-08 Ciba-Geigy Corp. Oral osmotic system for slightly soluble active agents
US5231089A (en) * 1991-12-02 1993-07-27 University Of Florida Method of improving oral bioavailability of carbamazepine
FR2702148B1 (fr) 1993-03-05 1995-04-07 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement du neuro-sida.
US5472714A (en) * 1993-09-08 1995-12-05 Ciba-Geigy Corporation Double-layered oxcarbazepine tablets
US5466683A (en) 1994-08-25 1995-11-14 Teva Pharmaceutical Industries Ltd. Water-soluble analogs of carbamazepine

Also Published As

Publication number Publication date
AU748034B2 (en) 2002-05-30
EP1033988B1 (en) 2004-01-07
US6316417B1 (en) 2001-11-13
IL135123A0 (en) 2001-05-20
US20020055503A1 (en) 2002-05-09
AR015465A1 (es) 2001-05-02
US6458770B1 (en) 2002-10-01
CZ298900B6 (cs) 2008-03-05
CA2304661C (en) 2007-12-11
TW584563B (en) 2004-04-21
CA2304661A1 (en) 1999-04-22
SK286253B6 (sk) 2008-06-06
KR100760326B1 (ko) 2007-09-20
EP1033988A1 (en) 2000-09-13
KR20010072533A (ko) 2001-07-31
CN1274286A (zh) 2000-11-22
HUP0004362A3 (en) 2006-06-28
AU9629898A (en) 1999-05-03
HUP0004362A2 (hu) 2001-08-28
CN1210032C (zh) 2005-07-13
NZ503526A (en) 2003-01-31
ID24134A (id) 2000-07-06
CO5090854A1 (es) 2001-10-30
NO20001730L (no) 2000-04-04
SK5052000A3 (en) 2000-12-11
DK1033988T3 (da) 2004-04-13
WO1999018966A1 (en) 1999-04-22
ES2214738T3 (es) 2004-09-16
DE69821024D1 (de) 2004-02-12
NO20001730D0 (no) 2000-04-04
HU226106B1 (en) 2008-04-28
JP2001519395A (ja) 2001-10-23
PT1033988E (pt) 2004-05-31
TR200000870T2 (tr) 2000-10-23
RU2242231C2 (ru) 2004-12-20
HK1031824A1 (en) 2001-06-29
DE69821024T2 (de) 2004-10-28
PL192287B1 (pl) 2006-09-29
JP2005281314A (ja) 2005-10-13
PL339446A1 (en) 2000-12-18
CZ20001279A3 (cs) 2000-07-12
ZA989183B (en) 1999-04-09
CO4950520A1 (es) 2000-09-01
MY122129A (en) 2006-03-31
NO327263B1 (no) 2009-05-25
BR9812861A (pt) 2000-08-08
ATE257383T1 (de) 2004-01-15
GB9721497D0 (en) 1997-12-10

Similar Documents

Publication Publication Date Title
PA8508701A1 (es) Composiciones farmaceuticas que proporcionan concentraciones potenciadas de farmaco
ES2131573T3 (es) Procedimiento para el replegamiento de igf-i a una conformacion activa.
BR9909681B1 (pt) estrutura de seringa.
BR0011205A (pt) Dispositivo eletrônico orgânico flexível, display eletroluminescente, fotodetector e método de aperfeiçoamento da resistência à degradação do oxigênio e da umidade
BR9811927A (pt) Dispositivo de liberação de agente benéfico propelido por gás que pode ser implantado
ES2032802T3 (es) Sucedaneo de la sangre, semisintetico, extrapuro.
CO4700491A1 (es) Sistema transcorneal de liberacion de medicamentos
GT199900158A (es) "combinaciones para la diabetes"
PE121998A1 (es) Formulacion parenteral de dibenz(b,f)azepin-5-carboxamida
DE50004443D1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
ES2189121T3 (es) Mezcla de estabilizantes para materiales organicos.
AR026302A1 (es) Un metodo para estabilizar solventes siliconados para la limpieza en seco, un adsorbente y un proceso de limpieza en seco.
BRPI0414979A (pt) preparação sólida
AR036887A1 (es) Dispositivo para liberacion de sustancias.
AR024959A1 (es) Una composicion farmaceutica liquida basada en paracetamol
BR9611343A (pt) Processo de solubilização d eum agente em um anfifìlico, composição, e, uso da mesma.
ES2166219T3 (es) Empleo de mezclas detergentes como solubilizantes.
AR019724A2 (es) Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas
AR025733A1 (es) Portador para transportador
PT1058735E (pt) Utilizacao de produtos quimicos que promovem a oxidacao na oxidacao de polimeros oxidaveis contendo configuracoes alcoolicas do tipo galactose
ATE263547T1 (de) Pharmazeutische mischung, die ein profen und weitere aktivsubstanzen enthält
AR022620A1 (es) Aroil aminoacil pirroles para ser usados en el tratamiento de dolor neuropatico
ES2184301T3 (es) Procedimiento para la preparacion de un derivado de desoxiuridina.
ES2180515T3 (es) Dispositivo de rotura controlada de una estructura que trabaja a traccion y equipo que aplica el mismo.
ES2139365T3 (es) Procedimiento de evacuacion de residuos de las aplicaciones transdermales de principios activos.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed